circPARPBP promotes cancer stemness and chemoresistance in triple-negative breast cancer through recruiting SRCAP complex to activate CCL20 transcription

Mao X, Ma K, Wang Y, Long C, Tan X, Chen X, et al. Characterizing neurofibromin 1-altered breast cancer through genomic, functional, and clinical analyses. Virchows Arch. 2025. https://doi.org/10.1007/s00428-025-04218-y.

Ma K, Mao X, Zhuang H, Long C, Chen B. Independent effects of mental health disorders on breast cancer and their mediating factors: evidence from NHANES and two-step Mendelian randomization. Discov Oncol. 2025;16:1533.

Article 
PubMed 
PubMed Central 

Google Scholar 

Leon-Ferre RA, Goetz MP. Advances in systemic therapies for triple negative breast cancer. BMJ. 2023;381:e071674.

Article 
CAS 
PubMed 

Google Scholar 

Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer – expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19:91–113.

Article 
CAS 
PubMed 

Google Scholar 

Fan M, Gao J, Zhou L, Xue W, Wang Y, Chen J, et al. Highly expressed SERCA2 triggers tumor cell autophagy and is a druggable vulnerability in triple-negative breast cancer. Acta Pharm Sin B. 2022;12:4407–23.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genetics. 2024;286-287:18–24.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Mao XD, Wei X, Xu T, Li TP, Liu KS. Research progress in breast cancer stem cells: characterization and future perspectives. Am J Cancer Res. 2022;12:3208–22.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Denkert C, Liedtke C, Tutt A, von Minckwitz G. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. Lancet. 2017;389:2430–42.

Article 
CAS 
PubMed 

Google Scholar 

Saygin C, Matei D, Majeti R, Reizes O, Lathia JD. Targeting cancer stemness in the clinic: from hype to hope. Cell Stem Cell. 2019;24:25–40.

Article 
CAS 
PubMed 

Google Scholar 

Jia D, Li L, Andrew S, Allan D, Li X, Lee J, et al. An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells. Cell Death Dis. 2017;8:e2932.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Sulaiman A, McGarry S, Lam KM, El-Sahli S, Chambers J, Kaczmarek S, et al. Co-inhibition of mTORC1, HDAC and ESR1alpha retards the growth of triple-negative breast cancer and suppresses cancer stem cells. Cell Death Dis. 2018;9:815.

Article 
PubMed 
PubMed Central 

Google Scholar 

Sun Z, Zhao M, Wang W, Hong L, Wu Z, Luo G, et al. 5-ALA mediated photodynamic therapy with combined treatment improves anti-tumor efficacy of immunotherapy through boosting immunogenic cell death. Cancer Lett. 2023;554:216032.

Article 
CAS 
PubMed 

Google Scholar 

Wang Q, Yang T, Li S, Xu C, Wang C, Xiong Y, et al. Unimolecular self-assembled hemicyanine-oleic acid conjugate acts as a novel succinate dehydrogenase inhibitor to amplify photodynamic therapy and eliminate cancer stem cells. Research. 2023;6:0223.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Wu S, Lu J, Zhu H, Wu F, Mo Y, Xie L, et al. A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer. Cancer Lett. 2024;581:216508.

Article 
CAS 
PubMed 

Google Scholar 

Huang X, Song C, Zhang J, Zhu L, Tang H. Circular RNAs in breast cancer diagnosis, treatment and prognosis. Oncol Res. 2023;32:241–9.

Article 
PubMed 
PubMed Central 

Google Scholar 

Dai D, Zhang J, Mo Y, Song C, Liu L, Chen ZS, et al. CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer. J Transl Int Med. 2025;13:267–80.

Article 
PubMed 
PubMed Central 

Google Scholar 

Zhang Y, Li C, Liu X, Wang Y, Zhao R, Yang Y, et al. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637. EBioMedicine. 2019;48:277–88.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Liu Y, Zhai R, Hu S, Liu J. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis. Anticancer Drugs. 2022;33:e186–e197.

Article 
CAS 
PubMed 

Google Scholar 

Wang X, Chen T, Li C, Li W, Zhou X, Li Y, et al. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR. J Hematol Oncol. 2022;15:122.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Zhang Z, Chen WQ, Zhang SQ, Bai JX, Liu B, Yung KK, et al. Isoliquiritigenin inhibits pancreatic cancer progression through blockade of p38 MAPK-regulated autophagy. Phytomedicine. 2022;106:154406.

Article 
CAS 
PubMed 

Google Scholar 

Xiang S, Jian L, Zeng H, Wu H, Ge B, Zhang P, et al. Isoliquiritigenin suppresses the progression of malignant melanoma via targeting H2A.Z.1-E2F1 pathway. Biochem Pharmacol. 2023;218:115859.

Article 
CAS 
PubMed 

Google Scholar 

Peng F, Tang H, Liu P, Shen J, Guan X, Xie X, et al. Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis. Sci Rep. 2017;7:9022.

Article 
PubMed 
PubMed Central 

Google Scholar 

Peng F, Tang H, Du J, Chen J, Peng C. Isoliquiritigenin suppresses EMT-induced metastasis in triple-negative breast cancer through miR-200c/C-JUN/β-catenin. Am J Chin Med. 2021;49:505–23.

Article 
CAS 
PubMed 

Google Scholar 

Xie Y, Xie J, Huang G, Zhang J, Song C, Luo Y, et al. Isoliquiritigenin reduces brain metastasis by circNAV3-ST6GALNAC5-EGFR axis in triple-negative breast cancer. Cancer Lett. 2025;624:217734.

Article 
CAS 
PubMed 

Google Scholar 

Zhou Z, Han S, Liao J, Wang R, Yu X, Li M. Isoliquiritigenin inhibits oral squamous cell carcinoma and overcomes chemoresistance by destruction of survivin. Am J Chinese Med. 2023;51:2221–41.

Article 
CAS 

Google Scholar 

Liu A, Jiang B, Song C, Zhong Q, Mo Y, Yang R, et al. Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR-1236/HER2 signaling pathway. MedComm. 2023;4:e282.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Chen B, Lai J, Dai D, Chen R, Liao N, Gao G, et al. PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer. Ther Adv Med Oncol. 2020;12:1758835920974212.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Chen B, Wei W, Huang X, Xie X, Kong Y, Dai D, et al. circEPSTI1 as a prognostic marker and mediator of triple-negative breast cancer progression. Theranostics. 2018;8:4003–15.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Yin Y, Yan Y, Fan B, Huang W, Zhang J, Hu HY, et al. Novel combination therapy for triple-negative breast cancer based on an intelligent hollow carbon sphere. Research (Wash D C). 2023;6:0098.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Xie J, Ye F, Deng X, Tang Y, Liang JY, Huang X, et al. Circular RNA: a promising new star of vaccine. J Transl Int Med. 2023;11:372–81.

Article 
PubMed 
PubMed Central 

Google Scholar 

Chen DL, Sheng H, Zhang DS, Jin Y, Zhao BT, Chen N, et al. The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p. Mol Cancer. 2021;20:166.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Zeng Y, Du W, Huang Z, Wu S, Ou X, Zhang J, et al. Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging miR-1205. Cell Death Discov. 2023;9:153.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Liu J, Wang H, Xiao S, Zhang S, Qi Y, Wang M. Circ_0000231 promotes paclitaxel resistance in ovarian cancer by regulating miR-140/RAP1B. Am J Cancer Res. 2023;13:872–85.

CAS 
PubMed 
PubMed Central 

Google Scholar 

Liu S, Sun Y, Hou Y, Yang L, Wan X, Qin Y, et al. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties. J Hematol Oncol. 2021;14:178.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Zhou M, Hou Y, Yang G, Zhang H, Tu G, Du YE, et al. LncRNA-Hh strengthen cancer stem cells generation in twist-positive breast cancer via activation of hedgehog signaling pathway. Stem Cells. 2016;34:55–66.

Article 
CAS 
PubMed 

Google Scholar 

Gu Y, Wang Y, He L, Zhang J, Zhu X, Liu N, et al. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling. Mol Cancer. 2021;20:132.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17:559–72.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Yu X, Yuan Z, Yang Z, Chen D, Kim T, Cui Y, et al. The novel long noncoding RNA u50535 promotes colorectal cancer growth and metastasis by regulating CCL20. Cell Death Dis. 2018;9:751.

Article 
PubMed 
PubMed Central 

Google Scholar 

Cheng XS, Li YF, Tan J, Sun B, Xiao YC, Fang XB, et al. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition. Cancer Lett. 2014;348:77–87.

Article 
CAS 
PubMed 

Google Scholar 

Jin P, Shin SH, Chun YS, Shin HW, Shin YJ, Lee Y, et al. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-kappaB signaling pathway. Oncogene. 2018;37:3070–87.

Article 
CAS 
PubMed 

Google Scholar 

Lee SK, Park KK, Kim HJ, Park J, Son SH, Kim KR, et al. Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis. Sci Rep. 2017;7:9610.

Article 
PubMed 
PubMed Central 

Google Scholar 

Wang D, Yang L, Yu W, Wu Q, Lian J, Li F, et al. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-kappaB signaling. J Immunother Cancer. 2019;7:215.

Article 
PubMed 
PubMed Central 

Google Scholar 

Chen W, Qin Y, Wang D, Zhou L, Liu Y, Chen S, et al. CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer. PLoS Biol. 2018;16:e2005869.

Article 
PubMed 
PubMed Central 

Google Scholar 

Meitei HT, Jadhav N, Lal G. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases. Autoimmunity reviews. 2021;20:102846.

Article 
CAS 
PubMed 

Google Scholar 

Skovdahl HK, Damås JK, Granlund AVB, Østvik AE, Doseth B, Bruland T, et al. C-C Motif Ligand 20 (CCL20) and C-C motif chemokine receptor 6 (CCR6) in human peripheral blood mononuclear cells: dysregulated in ulcerative colitis and a potential role for CCL20 in IL-1β release. Int J Mol Sci. 2018;19:3257.

Article 
PubMed 
PubMed Central 

Google Scholar 

Wang X, Zhang H, Chen X, Wu C, Ding K, Sun G, et al. Overcoming tumor microenvironment obstacles: current approaches for boosting nanodrug delivery. Acta Biomater. 2023;166:42–68.

Article 
CAS 
PubMed 

Google Scholar 

Muscella A, Vetrugno C, Marsigliante S. CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture. Mol Carcinogenesis. 2017;56:2461–73.

Article 
CAS 

Google Scholar 

Ouyang J, Hu S, Zhu Q, Li C, Kang T, Xie W, et al. RANKL/RANK signaling recruits Tregs via the CCL20-CCR6 pathway and promotes stemness and metastasis in colorectal cancer. Cell Death Dis. 2024;15:437.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Wang D, Yang L, Yu W, Wu Q, Lian J, Li F, et al. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling. J Immunother Cancer. 2019;7:215.

Article 
PubMed 
PubMed Central 

Google Scholar 

Famta P, Shah S, Jain N, Kumar KC, Bagasariya D, Khatri DK, et al. Tumor-promoting aftermath post-chemotherapy: A focus on breast cancer. Life Sci. 2022;310:121125.

Article 
CAS 
PubMed 

Google Scholar 

He HN, Wang X, Zheng XL, Sun H, Shi XW, Zhong YJ, et al. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity. Cancer Lett. 2010;295:38–43.

Article 
CAS 
PubMed 

Google Scholar 

Shi Z, Cao X, Ma Y, Li K, Wang X, Lin J, et al. RNA methyltransferase METTL16: From molecular mechanisms to therapeutic prospects in cancers. Cancer Lett. 2025;624:217698.

Article 
CAS 
PubMed 

Google Scholar 

Yin Z, Zhou Y, Zhu X, Goettl RA, Wang C, Weiss HL, et al. Cancer-associated fibroblast secreted DKK1 promotes the immunosuppressive tumor microenvironment and colorectal cancer resistance to chemotherapy. Cancer Lett. 2025;634:218060.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Cuadrado A, Corrado N, Perdiguero E, Lafarga V, Munoz-Canoves P, Nebreda AR. Essential role of p18Hamlet/SRCAP-mediated histone H2A.Z chromatin incorporation in muscle differentiation. EMBO J. 2010;29:2014–25.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Ye B, Liu B, Yang L, Zhu X, Zhang D, Wu W, et al. LncKdm2b controls self-renewal of embryonic stem cells via activating expression of transcription factor Zbtb3. EMBO J. 2018; 37.

Monroy MA, Schott NM, Cox L, Chen JD, Ruh M, Chrivia JC. SNF2-related CBP activator protein (SRCAP) functions as a coactivator of steroid receptor-mediated transcription through synergistic interactions with CARM-1 and GRIP-1. Mol Endocrinol. 2003;17:2519–28.

Article 
CAS 
PubMed 

Google Scholar 

Ghosh AK, Majumder M, Steele R, Yaciuk P, Chrivia J, Ray R, et al. Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP. J Biol Chem. 2000;275:7184–8.

Article 
CAS 
PubMed 

Google Scholar 

Cao W, Liu X, Su W, Liang H, Tang H, Zhang W, et al. LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the SNF2-related CREBBP activator protein (SRCAP). Bioengineered. 2022;13:4573–86.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Slupianek A, Yerrum S, Safadi FF, Monroy MA. The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells. J Cell Physiol. 2010;224:369–75.

Article 
CAS 
PubMed 

Google Scholar 

Dong S, Han J, Chen H, Liu T, Huen MSY, Yang Y, et al. The human SRCAP chromatin remodeling complex promotes DNA-end resection. Curr Biol. 2014;24:2097–110.

Article 
CAS 
PubMed 

Google Scholar 

Liu X, Zhao S, Xu X, Liu X, Zhang Y, Zhao S, et al. Circ(-)0008536 inhibits doxorubicin resistance in triple-negative breast cancer via the miR-382-5p/GGNBP2 axis. Transl Oncol. 2025;61:102526.

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Chen J, Li Y, Zheng Q, Bao C, He J, Chen B, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388:208–19.

Article 
CAS 
PubMed 

Google Scholar